Trevi Therapeutics, Inc.

Report date
3/31/2026
Quarter
2026 Q1
Filed
5/15/2026
Shares
9,939,547
Value ($000)
118,579
Weight
3.1%
2022 Q2 - 2026 Q1 (16 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).